Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer. J. Anal. Oncol. [Internet]. 2015 Jan. 9 [cited 2025 Nov. 7];4(1): 44-51. Available from: https://www.neoplasiaresearch.com/index.php/jao/article/view/242